Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Monte Rosa Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/26/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
03/31/2023 4 Skvarka Jan (Director) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Granted 41,000 options to buy @ $7.36, valued at $301.8k
03/24/2023 3 Skvarka Jan (Director) has filed a Form 3 on Monte Rosa Therapeutics, Inc.
01/04/2023 4 Wallace Owen B. (Chief Scientific Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Granted 135,000 options to buy @ $7.78, valued at $1.1M
01/04/2023 4 Warmuth Markus (President & CEO) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Granted 472,000 options to buy @ $7.78, valued at $3.7M
01/04/2023 4 Nickson Philip (General Counsel) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Granted 123,650 options to buy @ $7.78, valued at $962k
01/04/2023 4 Townson Sharon (Chief Technology Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Granted 78,550 options to buy @ $7.78, valued at $611.1k
01/04/2023 4 Jones Jullian G (Chief Business Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Granted 77,450 options to buy @ $7.78, valued at $602.6k
01/04/2023 4 Castle John C. (Chief Data Scientist) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Granted 78,500 options to buy @ $7.78, valued at $610.7k
01/04/2023 4 Tamboli Ajim (CFO) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Granted 129,850 options to buy @ $7.78, valued at $1M
01/04/2023 4 Janku Filip (Chief Medical Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Granted 135,000 options to buy @ $7.78, valued at $1.1M
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Jones Jullian G (Chief Business Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Granted 73,300 options to buy @ $13.41, valued at $983k
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2021 3 Jones Julian G (Chief Business Officer) has filed a Form 3 on Monte Rosa Therapeutics, Inc.
06/30/2021 4 Yang Rick (10% Owner) has filed a Form 4 on Monte Rosa Therapeutics, Inc.
Txns: Converted 2,715,968 shares @ $0
Converted 3,257,328 shares @ $0
Converted 669,002 shares @ $0
Bought 1,050,000 shares @ $19, valued at $20M
Converted 9,588,725 convertible preferred @ $0
Converted 11,500,000 convertible preferred @ $0
Converted 2,361,912 convertible preferred @ $0
06/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy